Ionis Pharmaceuticals Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

81.46 4.28

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

77.45

Max

82.47

Pagrindiniai rodikliai

By Trading Economics

Pajamos

136M

-93M

Pardavimai

43M

246M

Pelnas, tenkantis vienai akcijai

-0.3

Pelno marža

-37.599

Darbuotojai

1,402

EBITDA

-4.7B

-69M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+36.71% upside

Dividendai

By Acuity

Kitas uždarbis

2026-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

759M

13B

Ankstesnė atidarymo kaina

77.18

Ankstesnė uždarymo kaina

81.46

Naujienos nuotaikos

By Acuity

50%

50%

141 / 342 reitingas Healthcare

Ionis Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-06-25 23:51; UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

2026-06-25 23:51; UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

2026-06-25 23:51; UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

2026-06-25 23:42; UTC

News
Macro News
ETF Constituents

The Vanguard Information Technology ETF rose in after-market trading, boosted by Micron's strong earnings and revenue forecast, despite mixed broader market sentiment.

2026-06-25 23:41; UTC

ETF Constituents
Social Media
News
Correlated Moves

SPDR S&P 500 ETF Trust trades higher after market close, supported by positive returns from top holdings like Microsoft and Apple amid mixed market sentiment.

2026-06-25 23:41; UTC

News
ETF Constituents
Social Media

Invesco QQQ Trust Series I rises in after-market hours, supported by a gain in the Nasdaq 100. Microsoft, Apple, and Meta contributed positively to performance.

2026-06-25 23:41; UTC

News
Social Media

Apple Inc. has raised prices for its MacBook and iPad models due to higher memory and storage costs. Shares are advancing in after-market trading.

2026-06-25 23:41; UTC

Social Media
News

Microsoft shares are higher in after-market trading following Thursday's close. Analysts are cautious amid rising console storage costs and AI spending concerns.

2026-06-25 23:26; UTC

News
ETF Constituents
Social Media

Vanguard Growth ETF shares advanced in after-market trading, supported by gains from Microsoft, Apple, and Meta, following four sessions of declines.

2026-06-25 23:22; UTC

News

Tesla's energy division may drive growth amid EV market challenges. Shares traded roughly flat during after-market hours following Thursday's close.

2026-06-25 23:06; UTC

ETF Constituents
News

The SPDR Dow Jones Industrial Average ETF Trust is higher in after-market trading, supported by positive economic data and contributions from Microsoft and Goldman Sachs.

2026-06-25 20:07; UTC

News
Macro Event
Correlated Moves

The USD/SEK exchange rate is lower today, influenced by upward revisions in US GDP growth and personal spending figures.

2026-06-25 20:07; UTC

News

Starbucks shares are lower despite reports of U.S. sales growth and upgraded earnings guidance. The stock pulled back from earlier session highs amid broader market dynamics.

2026-06-25 20:07; UTC

Macro Event
News

Positive U.S. macroeconomic indicators lift USD/NOK, which is trading higher since Wednesday's close and remains near the upper end of its one-month range.

2026-06-25 20:07; UTC

Macro Event
News

The USD/CZK exchange rate remains roughly flat, influenced by recent U.S. economic reports, including an upward revision of Q1 GDP growth to 2.1%.

2026-06-25 20:07; UTC

Correlated Moves
News
Macro Event

The USD/PLN is trading lower today, influenced by recent U.S. economic data and a slight decline in the US Dollar Index.

2026-06-25 20:07; UTC

News
Macro Event
Correlated Moves

The USD/HUF exchange rate is lower today, reflecting a slight decline since Wednesday. U.S. macroeconomic data contributed to recent volatility in the currency pair.

2026-06-25 20:07; UTC

Correlated Moves
Macro Event
News

The USD/DKK exchange rate is declining, influenced by upward revisions in US GDP growth and muted responses to personal income and spending data.

2026-06-25 20:07; UTC

News
Correlated Moves

The GBP/HKD exchange rate is rising, supported by an increase in GBP/USD amid ongoing inflation concerns and geopolitical tensions in the Strait of Hormuz.

2026-06-25 20:07; UTC

News
Correlated Moves

Ethereum is lower today, influenced by Bitcoin's decline. It remains below its 20-day moving average and has finished lower for three consecutive sessions.

2026-06-25 20:07; UTC

Correlated Moves
Macro Event
News

Bitcoin is lower today, impacted by the expiration of $10 billion in options and geopolitical tensions. Ethereum also declines, reflecting similar market conditions.

2026-06-25 20:07; UTC

Macro Event
News
Correlated Moves

Bitcoin is lower today, driven by the expiration of $10 billion in options and geopolitical tensions following an attack in the Strait of Hormuz.

2026-06-25 20:06; UTC

News

The Nikkei 225 Index is higher in after-market hours, supported by earlier gains and remaining above its 20-day moving average. No specific news was identified.

2026-06-25 19:56; UTC

ETF Constituents
News
Correlated Moves

Vanguard Real Estate ETF is higher as Simon Property Group and Welltower contribute positively, despite uncertainty from the postponed housing affordability bill.

2026-06-25 19:56; UTC

News
Macro Event
Social Media

Geopolitical tensions from an attack on a cargo ship have pressured U.S. Treasury yields, contributing to a decline in the iShares 20+ Year Treasury Bond ETF.

2026-06-25 19:46; UTC

Correlated Moves
News

Ethereum is trading lower amid persistent inflation and geopolitical tensions affecting oil supply. The asset remains below its 20-day moving average.

2026-06-25 19:26; UTC

News

Sirius XM Holdings Inc. is lower amid mixed US market performance and declines in major tech stocks, reflecting profit-taking and valuation concerns.

2026-06-25 19:16; UTC

Correlated Moves
News

The U.S. core PCE price index rose in May, suggesting ongoing inflation. The Vanguard Mortgage-Backed Securities ETF is trading higher since Wednesday's close.

2026-06-25 19:16; UTC

Macro Event
Correlated Moves
News

The Vanguard Total Bond Market ETF is higher today, supported by rising inflation data and an upward revision in Q1 GDP growth, reflecting stronger economic activity.

2026-06-24 23:56; UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Ionis Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

36.71% į viršų

12 mėnesių prognozė

Vidutinis 104.61 USD  36.71%

Aukščiausias 130 USD

Žemiausias 75 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ionis Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

17

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

141 / 342 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.
help-icon Live chat